Koraljka Gall Troselj
Overview
Explore the profile of Koraljka Gall Troselj including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
300
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zlendic M, Vrbanovic duricic E, Gall Troselj K, Tomljanovic M, Derfi K, Alajbeg I
Int J Mol Sci
. 2024 Aug;
25(16).
PMID: 39201416
This case-control study investigated single nucleotide polymorphism (SNP) genotypes (CXC motif chemokine ligand 8 (): rs2227306 and rs2227307 and tumor necrosis factor (): rs1800629) in 85 patients with pain-related temporomandibular...
2.
Zlendic M, Vrbanovic E, Gall Troselj K, Tomljanovic M, Derfi K, Alajbeg I
J Oral Rehabil
. 2024 May;
51(8):1542-1554.
PMID: 38725226
Background: Single nucleotide polymorphisms (SNPs) may influence pain susceptibility and impact treatment response in pain-related temporomandibular disorders (TMDp). Objective: Explore the role of COMT (rs4646310, rs6269, rs4818, rs4680) and OPRM1...
3.
Blazekovic I, Samija I, Perisa J, Gall Troselj K, Regovic Dzombeta T, Radulovic P, et al.
Biomedicines
. 2024 Mar;
12(3).
PMID: 38540091
The early identification of aggressive forms of cancer is of high importance in treating papillary thyroid cancer (PTC). Disease dissemination is a major factor influencing patient survival. Mutation status of...
4.
Pouliquen D, Gall Troselj K, Anto R, Naidu R
Front Pharmacol
. 2023 Sep;
14:1266793.
PMID: 37675041
No abstract available.
5.
Pouliquen D, Gall Troselj K, Anto R
Pharmaceutics
. 2023 Jun;
15(6).
PMID: 37376060
The number of published studies on curcuminoids in cancer research, including its lead molecule curcumin and synthetic analogs, has been increasing substantially during the past two decades. Insights on the...
6.
Vrbanovic E, Zlendic M, Gall Troselj K, Tomljanovic M, Derfi K, Alajbeg I
Antioxidants (Basel)
. 2023 Jun;
12(6).
PMID: 37371925
The frequency of selected polymorphisms, one in each gene coding for proteins with antioxidative properties ((rs1001179), (rs4880), (rs1050450), and (rs689452)), was compared between patients suffering from pain-related temporomandibular disorders (TMDp;...
7.
Association of oral behaviours and psychological factors with selected genotypes in pain-related TMD
Zlendic M, Vrbanovic E, Tomljanovic M, Gall Troselj K, Derfi K, Alajbeg I
Oral Dis
. 2023 Apr;
30(3):1702-1715.
PMID: 37036392
Objectives: To investigate frequency of single nucleotide polymorphisms (SNPs) in pain-related temporomandibular disorders (TMDp) and to determine whether specific SNPs, psychological, psychosomatic and behavioural characteristics are predictive for pain existence...
8.
Samarzija I, Gall Troselj K, Konjevoda P
Cancers (Basel)
. 2023 Feb;
15(4).
PMID: 36831650
Prostate cancer is among the leading cancers according to both incidence and mortality. Due to the high molecular, morphological and clinical heterogeneity, the course of prostate cancer ranges from slow...
9.
Samarzija I, Tomljanovic M, Novak Kujundzic R, Gall Troselj K
Cancers (Basel)
. 2022 Oct;
14(19).
PMID: 36230683
Anticancer monotherapies are often insufficient in eradicating cancer cells because cancers are driven by changes in numerous genes and pathways. Combination anticancer therapies which aim to target several cancer traits...
10.
Gall Troselj K, Tomljanovic M, Jaganjac M, Glavan T, cipak Gasparovic A, Milkovic L, et al.
Molecules
. 2022 Mar;
27(5).
PMID: 35268568
Oxidative stress and its end-products, such as 4-hydroxynonenal (HNE), initiate activation of the Nuclear Factor Erythroid 2-Related Factor 2 (NRF2)/Kelch Like ECH Associated Protein 1 (KEAP1) signaling pathway that plays...